COZZI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.412
AS - Asia 6.896
EU - Europa 3.172
SA - Sud America 1.043
AF - Africa 1.017
Continente sconosciuto - Info sul continente non disponibili 145
OC - Oceania 87
Totale 23.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.800
SG - Singapore 2.216
VN - Vietnam 1.219
CN - Cina 1.090
HK - Hong Kong 659
IT - Italia 646
BR - Brasile 622
DE - Germania 310
FI - Finlandia 305
FR - Francia 292
IN - India 218
BD - Bangladesh 214
SE - Svezia 164
PL - Polonia 157
UA - Ucraina 146
GB - Regno Unito 131
RU - Federazione Russa 120
IQ - Iraq 109
CA - Canada 96
AR - Argentina 94
TR - Turchia 91
JP - Giappone 86
NL - Olanda 81
ID - Indonesia 76
PK - Pakistan 76
IE - Irlanda 73
PH - Filippine 69
SA - Arabia Saudita 63
EC - Ecuador 57
MX - Messico 56
ZA - Sudafrica 53
VE - Venezuela 51
UZ - Uzbekistan 49
CO - Colombia 48
ES - Italia 44
JM - Giamaica 44
MA - Marocco 43
GR - Grecia 42
EG - Egitto 41
AT - Austria 40
PS - Palestinian Territory 40
PY - Paraguay 40
AE - Emirati Arabi Uniti 38
CZ - Repubblica Ceca 38
BY - Bielorussia 37
JO - Giordania 37
MY - Malesia 37
SO - Somalia 35
AZ - Azerbaigian 34
KZ - Kazakistan 34
PA - Panama 34
BE - Belgio 33
IL - Israele 33
SN - Senegal 33
IR - Iran 32
NI - Nicaragua 32
SI - Slovenia 32
TN - Tunisia 32
AL - Albania 31
BG - Bulgaria 31
GA - Gabon 31
KE - Kenya 31
KR - Corea 31
RO - Romania 31
CM - Camerun 30
DZ - Algeria 30
ET - Etiopia 30
KG - Kirghizistan 30
DO - Repubblica Dominicana 29
KH - Cambogia 29
PT - Portogallo 29
AO - Angola 28
CG - Congo 28
CH - Svizzera 28
EE - Estonia 28
UG - Uganda 28
UY - Uruguay 28
BZ - Belize 27
CL - Cile 27
CW - ???statistics.table.value.countryCode.CW??? 27
GF - Guiana Francese 27
TT - Trinidad e Tobago 27
CI - Costa d'Avorio 26
CR - Costa Rica 26
CU - Cuba 26
HN - Honduras 26
MU - Mauritius 26
XK - ???statistics.table.value.countryCode.XK??? 26
AM - Armenia 25
AU - Australia 25
CV - Capo Verde 25
GN - Guinea 25
PR - Porto Rico 25
TW - Taiwan 25
DK - Danimarca 24
GH - Ghana 24
GT - Guatemala 24
MD - Moldavia 24
PE - Perù 24
RS - Serbia 24
Totale 22.568
Salva come PNG Salva come JPEG
Città #
Singapore 1.331
San Jose 1.088
Ashburn 1.064
Fairfield 963
Chandler 722
Woodbridge 611
Ann Arbor 609
Houston 598
Hong Kong 588
Jacksonville 481
Wilmington 410
Ho Chi Minh City 360
Cambridge 319
Seattle 318
Hanoi 314
Santa Clara 302
Princeton 230
Los Angeles 227
Boardman 223
Beijing 165
Des Moines 164
Lauterbourg 143
Helsinki 136
San Diego 120
Council Bluffs 112
Bytom 111
Nanjing 107
Medford 104
New York 87
Roxbury 65
Dublin 64
Da Nang 60
São Paulo 54
Guangzhou 52
Haiphong 52
Munich 52
Buffalo 50
Milan 49
Chicago 46
Tokyo 46
Baghdad 45
Orem 45
Tashkent 41
Padova 38
Chennai 37
Rome 37
Amman 34
Baku 33
Biên Hòa 33
Dakar 33
Managua 32
Dallas 31
Hebei 29
Libreville 29
Panama City 29
Kampala 28
Nairobi 28
Phnom Penh 28
Tianjin 28
Vienna 28
Abidjan 26
Jeddah 26
London 26
Conakry 25
Kingston 25
Nanchang 25
Athens 24
Montevideo 24
Amsterdam 23
Bishkek 23
Jiaxing 23
Praia 23
Addis Ababa 22
Atlanta 22
Brooklyn 22
Castries 22
Frankfurt am Main 22
Havana 22
Johannesburg 22
Montreal 22
Shenyang 22
Yerevan 22
Cayenne 21
Hargeisa 21
Hefei 21
Luanda 21
Minsk 21
Naples 21
Riyadh 21
San José 21
Ulan Bator 21
Accra 20
Antananarivo 20
Dushanbe 20
Harare 20
Nassau 20
Quito 20
Riga 20
Tallinn 20
Changsha 19
Totale 14.144
Salva come PNG Salva come JPEG
Nome #
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 361
Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti. 308
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature. 284
Therapy of scleroderma renal crisis: State of the art 281
Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study 268
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 266
Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients 266
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction 265
Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review 258
Effets du traitement par les bains de boue dans le rhumatisme psoriasique chez les patients traités par anti-TNF. Évaluation clinique et par échographie de contraste de l'inflammation synoviale 251
Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area 250
Effects of mud-bath therapy in psoriatic arthritis patients treated with TNF inhibitors. Clinical evaluation and assessment of synovial inflammation by contrast-enhanced ultrasound (CEUS). 244
Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis. 243
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 236
The power of the EUSTAR cohort: key findings to date and implicationsfor management of systemic sclerosis patients 236
Prognosis of scleroderma renal crisis: a long-term observational study. 234
High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis 234
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 231
Unstabilized DNA breaks in lymphocytes of patients with different subsets of systemic sclerosis 229
Plasma-exchange as a "rescue therapy" for dermato/polymyositis in acute phase. Experience in three young patients 229
[Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases] 222
Long-term improvement in activities of daily living in women with systemic sclerosis attending to occupational therapy. 222
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 220
La terapia dell'artrite reumatoide mediante levamisolo. 218
Right heart function by 3D-echocardiography and 2D-speckle tracking in scleroderma patients in absence of pulmonary hypertension 218
Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? 214
Adult Henoch-Schonlein purpura with glomerulonephritis and paroxysmal nocturnal haemoglobinuria: an uncommon association 210
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group 206
PD-1 gene rs2227981 (PD-1.5) polymorphism analysis in patients with systemic sclerosis 203
How I treat patients with systemic sclerosis in clinical practice 201
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 200
Short-term effects of plasma exchange on coagulation factors in a sclerodermic patient. 194
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis 194
Mud-bath treatment in spondylitis associated with inflammatory bowel disease - a pilot randomised clinical trial. 190
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. 189
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 189
Right ventricular function by 3D-echocardiography and 2D-speckle tracking in scleroderma patients in absence of pulmonary hypertension 187
Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis 186
Trattamento con innesti di tessuto adiposo della fibrosi cutanea periorale in pazienti affette da sclerosi sistemica progressiva 185
Causes and risk factors for death in systemic sclerosis. A study from the EULAR Scleroderma Trials And Research (EUSTAR) data base. 184
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study. 184
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. 184
Trattamento con innesti di tessuto adiposo della fibrosi cutanea periorale in pazienti affette da sclerosi sistemica progressiva 183
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 182
Anti-inflammatory effect of mud-bath applications on adjuvant arthritis in rats 181
Effect of Bosentan on Plasma Markers of Endothelial Cell Activity in Patients with Secondary Pulmonary Hypertension Related to Connective Tissue Diseases. 181
Antifibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts. 177
The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors. 177
Mapping and predicting mortality from systemic sclerosis 177
Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients 176
Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not inSjogren's Syndrome, Salivary Glands. 176
Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study. 176
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 170
Aprroccio Riabilitativo alla sclerodermia. 168
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients. 164
Left atrial remodeling and dysfunction occur early in patients with systemic sclerosis and normal left ventricular function 164
Prevalenza e significato clinico degli anticorpi anti-catepsina G nella sclerosi sistemica. 161
Right ventricular mechanics changes according to pressure overload increasing, a 2D-speckle tracking echocardiographic evaluation 160
Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: Dual-1 and Dual-2 randomized clinical trials 157
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: A 10-year longitudinal study from the EUSTAR database 156
Incidence of subclinical myocardial dysfunction in patients with systemic sclerosis and normal left ventricular systolic and diastolic function. 156
Neuroendocrine effects of a cycle of fangotherapy 156
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 155
The social costs of digital ulcer management in sclerodema patients: An observational Italian pilot study 154
Systemic sclerosis in a patient with recent nasopharyngeal carcinoma: an unusual combination. 154
Left ventricular subclinical dysfunction by 2D-speckle tracking in systemic sclerosis patients according to autoantibody pattern 153
Clinical manifestations and outcome of polyarthralgia associated with chronic lymphocytic thyroiditis 152
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis 150
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 150
[Digital ulcers in a cohort of 333 scleroderma patients] 146
Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis. 146
Lacrimal defects in adult and senile rheumatoid arthritis. 145
Bosentan may induce arthritis flare in sclerodermia patients concomitantly treated with methotrexate. 145
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases.] 143
Hypothalamic-pituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. 142
The role of plasma exchange in the management of autoimmune disorders 139
Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produceprofibrotic chemokines, with partial exploitation of toll-like receptor 4. 139
Effects of mud-bath applications on synovial inflammation evaluated by contrasted-enhanced ultrasound (CEUS) in patients with psoriatic arthritis 139
NITRIC OXIDE DIFFUSION IN PATIENTS WITH SSc 139
Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial 139
Digital ulcers predict a worse disease course in patients with systemic sclerosis 137
Autoantibodies to Bactericidal/Permeability-Increasing Protein and Cathepsin G in Systemic Sclerosis 133
BONE EFFECTS OF MUD-BATH THERAPY IN THE EUGANEAN AREA. A DENSITOMETRIC AND METABOLIC STUDY 129
Sclerodermia 128
Mortality and morbility in Italian patients with Sjögren syndrome. 128
Capillary Blood Volume Measurement In Scleroderma Patients Submitted To Nitric Oxide Diffusion Test 128
Socioeconomic costs of digital ulcer treatment among patients with systemic sclerosis: A pilot observational study in Italy 128
Gli autoanticorpi antitissutali durante la terapia con levamisolo nell'artrite reumatoide. 127
CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis. 125
Long-term therapy with plasma-exchange in systemic sclerosis: effects on laboratory markers reflecting the disease activity 124
Pentraxins, anti-pentraxins antibodies and atherosclerosis 122
Brief Report: Successful pregnancies but a higher riskof preterm births in patients with systemic sclerosis: An Italian multicenterstudy 121
Hypovitaminosis D in an hospitalized old population of Western Friuli 118
Mixed connective tissue disease (MCTD): one diagnosis, more evolutions. 118
Heparin, cartopril and dermatansulphate are ineffective in preventing bleomycin-induced lung fibrosis in rats. 118
Prevalenza e caratteristiche cliniche della fibromialgia nelle connettiviti maggiori: lupus eritematoso sistemico, sclerosi sistemica e sindrome di Sjögren primitiva. 116
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. 114
Levels of neuropeptides in bronchoalveolar lavage (BAL) fluids of patients with systemic sclerosis. 112
Induced sputum : a non-invasive tool for evaluation of lung involvement and alveolar inflammation in systemic sclerosis. 111
Efficacy of mud-bath treatment in spondylitis associated with inflammatory bowel disease. 111
Totale 18.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.509
article - articoli 60.929
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.304
Totale 130.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.550 0 276 135 131 52 103 68 156 67 31 145 386
2022/20231.533 319 136 30 171 253 279 4 104 172 13 44 8
2023/2024598 31 95 53 45 41 47 18 25 53 39 72 79
2024/20252.922 4 267 130 164 390 91 108 301 254 89 445 679
2025/202611.525 401 1.107 1.432 1.557 1.013 546 1.740 1.073 1.310 689 412 245
2026/2027614 305 309 0 0 0 0 0 0 0 0 0 0
Totale 23.772